Study highlights lack of VC funding in emerging markets

A recent article in Nature Biotechnology highlighted a lack of venture capital (VC) funding in certain emerging markets. The authors estimated that from 2000 to 2012, innovative VC and PE financing for Chinese, Indian, Brazilian and South African research-based companies totalled $1.7 billion – this is in comparison to the $1.1 billion of VC investment US research companies received in …